Results for "Understanding Pharmaceutical Distribution"
Envisioning the Future of the Pharmaceutical Supply Chain
Through a collaboration with the Milken Institute, HDA, along with diverse thought leaders and experts, provided expertise to inform a new report from the Milken Institute’s Center for Public Health. The report “Envisioning the Future of the Pharmaceutical Supply Chain to Advance Public Health in the United States,” emphasizes how a resilient pharmaceutical supply chain bolsters a strong public health infrastructure in the U.S, and brings a greater focus and awareness into supply chain collaboration to create an enhanced public health environment that is equitable, sustainable and resilient.
Advocacy in Action: TopRx Provides On-the-Ground Perspective During Rep. Kustoff’s Facility Visit
On May 4, HDA distributor member company TopRx gave a tour of their headquarters in Bartlett, Tenn., to Representative David Kustoff (R-Tenn.-08).
HDA Issues Policy Platform Addressing Drug Shortages
HDA and its pharmaceutical distributor members released a policy agenda to combat drug shortages, centering around three core themes: federal coordination, strategic investment and end-to-end stabilization of the generic drug supply chain.
A Conversation With Trinh Clark, Henry Schein’s Chief Global Customer Experience Officer
HDA distributor members are investing in optimizing the user experience for their manufacturer partners and pharmacy and provider customers — with efficiency, reliability, and security in mind. In line with this focus, Henry Schein recently launched a new Global Customer Experience Organization, led by Trinh Clark, SVP and Chief Global Customer Experience Officer.As part of HDA’s Faces of the Supply Chain series, we recently sat down with Clark to discuss her new function, the company’s adoption of cutting-edge technologies like artificial intelligence (AI), and her role as a leader in Henry Schein’s employee resource groups (ERGs) and diversity, equity and inclusion efforts.